Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 110 articles:
HTML format

Single Articles

    January 2022
  1. YANAGISAWA S, Nagasaki K, Chea C, Ando T, et al
    Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model.
    PLoS One. 2022;17:e0263254.
    PubMed     Abstract available

  2. LIU C, Fan F, Zhong L, Su J, et al
    Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology.
    PLoS One. 2022;17:e0262469.
    PubMed     Abstract available

  3. NGUYEN THP, Hokstad I, Fagerland MW, Mollnes TE, et al
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
    PLoS One. 2022;17:e0264628.
    PubMed     Abstract available

  4. HU J, Zhao L, Li N, Yang Y, et al
    Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation.
    PLoS One. 2022;17:e0264786.
    PubMed     Abstract available

  5. YASUDA T, Tahara K, Sawada T
    Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis.
    PLoS One. 2022;17:e0265687.
    PubMed     Abstract available

  6. WHITE IR, Kleinstein SE, Praet C, Chamberlain C, et al
    A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
    PLoS One. 2022;17:e0261165.
    PubMed     Abstract available

  7. SHIRAISHI K, Chiba K, Watanabe K, Oki N, et al
    Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes.
    PLoS One. 2022;17:e0265833.
    PubMed     Abstract available

  8. NAM SH, Ahn SM, Oh JS, Hong S, et al
    Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients.
    PLoS One. 2022;17:e0267715.
    PubMed     Abstract available

  9. GENC D, Bulut O, Gunaydin B, Goksu M, et al
    Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjogren's syndrome murine model.
    PLoS One. 2022;17:e0266137.
    PubMed     Abstract available

  10. GHOURI M, Ismail M, Zaidi SA, Rehman S, et al
    Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.
    PLoS One. 2022;17:e0268496.
    PubMed     Abstract available

  11. DESSIE G
    Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    PLoS One. 2022;17:e0269431.
    PubMed     Abstract available

  12. LI Z, Mu Y, Guo C, You X, et al
    Analysis of the saliva metabolic signature in patients with primary Sjogren's syndrome.
    PLoS One. 2022;17:e0269275.
    PubMed     Abstract available

  13. MORI S, Okada A, Koga T, Ueki Y, et al
    Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
    PLoS One. 2022;17:e0270391.
    PubMed     Abstract available

  14. MIKAMI S, Miura Y, Kondo S, Sakai K, et al
    Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.
    PLoS One. 2022;17:e0270056.
    PubMed     Abstract available

  15. GONI M, Basu N, Murray AD, Waiter GD, et al
    Brain predictors of fatigue in rheumatoid arthritis: A machine learning study.
    PLoS One. 2022;17:e0269952.
    PubMed     Abstract available

    January 2021
  16. PTACEK J, Hawtin RE, Sun D, Louie B, et al
    Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity.
    PLoS One. 2021;16:e0244187.
    PubMed     Abstract available

  17. BECART S, Whittington KB, Prislovsky A, Rao NL, et al
    The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
    PLoS One. 2021;16:e0245541.
    PubMed     Abstract available

  18. DIAZ-RUBIO GI, Corona-Meraz FI, Madrigal-Ruiz PM, Robles-De Anda JA, et al
    CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis.
    PLoS One. 2021;16:e0246054.
    PubMed     Abstract available

  19. LEDON-LLANES L, Contreras-Yanez I, Guaracha-Basanez G, Valverde-Hernandez SS, et al
    Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study.
    PLoS One. 2021;16:e0245538.
    PubMed     Abstract available

  20. GALVEZ-SANCHEZ CM, de la Coba P, Colmenero JM, Reyes Del Paso GA, et al
    Attentional function in fibromyalgia and rheumatoid arthritis.
    PLoS One. 2021;16:e0246128.
    PubMed     Abstract available

  21. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Sominanda A, et al
    Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-alpha, IL-1beta, IL-10 and IL-17A.
    PLoS One. 2021;16:e0246111.
    PubMed     Abstract available

  22. GAURAV R, Mikuls TR, Thiele GM, Nelson AJ, et al
    High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis.
    PLoS One. 2021;16:e0240707.
    PubMed     Abstract available

  23. SHUKLA R, Ganeshani M, Agarwal M, Jangir R, et al
    Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.
    PLoS One. 2021;16:e0246195.
    PubMed     Abstract available

  24. Expression of Concern: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0247971.

  25. GOSSELT HR, Vallerga CL, Mandaviya PR, Lubberts E, et al
    Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients.
    PLoS One. 2021;16:e0247709.
    PubMed     Abstract available

  26. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0248151.
    PubMed     Abstract available

  27. DREVINGE C, Scheffler JM, Koro-Arvidsson C, Sundh D, et al
    Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
    PLoS One. 2021;16:e0249205.
    PubMed     Abstract available

  28. SLOT LM, Vergroesen RD, Kerkman PF, Staudinger E, et al
    Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.
    PLoS One. 2021;16:e0247847.
    PubMed     Abstract available

  29. Correction to Expression of Concern on: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0249512.
    PubMed     Abstract available

  30. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    PubMed     Abstract available

  31. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    PubMed     Abstract available

  32. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    PubMed     Abstract available

  33. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    PubMed     Abstract available

  34. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    PubMed     Abstract available

  35. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    PubMed     Abstract available

  36. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available

  37. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    PubMed     Abstract available

  38. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    PubMed     Abstract available

  39. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    PubMed     Abstract available

  40. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    PubMed     Abstract available

  41. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    PubMed     Abstract available

  42. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed     Abstract available

  43. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed     Abstract available

  44. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    PubMed     Abstract available

  45. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    PubMed     Abstract available

  46. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
    The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
    PLoS One. 2021;16:e0246051.
    PubMed     Abstract available

  47. MINAMINO H, Katsushima M, Hashimoto M, Fujita Y, et al
    Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database.
    PLoS One. 2021;16:e0255526.
    PubMed     Abstract available

  48. LIN PH, Yu SF, Chen JF, Chen YC, et al
    Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
    PLoS One. 2021;16:e0255542.
    PubMed     Abstract available

  49. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    PubMed     Abstract available

  50. TRIKHA R, Greig D, Sekimura T, Cevallos N, et al
    Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection.
    PLoS One. 2021;16:e0250910.
    PubMed     Abstract available

  51. GONZALEZ-PONCE F, Gamez-Nava JI, Perez-Guerrero EE, Saldana-Cruz AM, et al
    Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    PLoS One. 2021;16:e0255854.
    PubMed     Abstract available

  52. CHI C, Taylor KE, Quach H, Quach D, et al
    Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren's syndrome.
    PLoS One. 2021;16:e0248429.
    PubMed     Abstract available

  53. KHALED SAA, Mahmoud HFF
    Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: A comparative analytic study.
    PLoS One. 2021;16:e0257200.
    PubMed     Abstract available

  54. KARYDIS A, Sandal I, Luo J, Prislovsky A, et al
    Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.
    PLoS One. 2021;16:e0250177.
    PubMed     Abstract available

  55. DIAZ-GALLO LM, Brynedal B, Westerlind H, Sandberg R, et al
    Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.
    PLoS One. 2021;16:e0250282.
    PubMed     Abstract available

  56. TURESSON WADELL A, Barebring L, Hulander E, Gjertsson I, et al
    Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis).
    PLoS One. 2021;16:e0258716.
    PubMed     Abstract available

  57. NAKAE K, Masui S, Yonezawa A, Hashimoto M, et al
    Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.
    PLoS One. 2021;16:e0258601.
    PubMed     Abstract available

  58. LIU W, Ma W, Liu H, Li C, et al
    Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies.
    PLoS One. 2021;16:e0248564.
    PubMed     Abstract available

  59. SHIBATA K, Yoshimura A, Ikeuchi S, Ishii M, et al
    Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations.
    PLoS One. 2021;16:e0253513.
    PubMed     Abstract available

  60. DOS SANTOS LP, Santo RCDE, Ramis TR, Portes JKS, et al
    The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.
    PLoS One. 2021;16:e0259574.
    PubMed     Abstract available

  61. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
    Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
    PLoS One. 2021;16:e0260254.
    PubMed     Abstract available

  62. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
    Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    PLoS One. 2021;16:e0259389.
    PubMed     Abstract available

  63. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
    Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
    PLoS One. 2021;16:e0256135.
    PubMed     Abstract available

  64. SEMBLER-MOLLER ML, Belstrom D, Locht H, Pedersen AML, et al
    Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjogren's syndrome.
    PLoS One. 2021;16:e0258428.
    PubMed     Abstract available

  65. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available

  66. FUJITA Y, Yago T, Asano T, Matsumoto H, et al
    Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
    PLoS One. 2021;16:e0255493.
    PubMed     Abstract available

  67. NOH ASM, Chuan TD, Khir NAM, Zin AAM, et al
    Effects of different doses of complete Freund's adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis.
    PLoS One. 2021;16:e0260423.
    PubMed     Abstract available

  68. O'BRIEN P, Conley B, Bunzli S, Bullen J, et al
    Staying moving, staying strong: Protocol for developing culturally appropriate information for Aboriginal people with osteoarthritis, rheumatoid arthritis, lupus and gout.
    PLoS One. 2021;16:e0261670.
    PubMed     Abstract available

  69. CHENG BR, Chen JQ, Zhang XW, Gao QY, et al
    Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0261239.
    PubMed     Abstract available

  70. RUDD PA, Lim EXY, Stapledon CJM, Krishnan R, et al
    Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.
    PLoS One. 2021;16:e0255125.
    PubMed     Abstract available

  71. MIN HK, Kim SH, Park Y, Lee KA, et al
    Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjogren's syndrome.
    PLoS One. 2021;16:e0259519.
    PubMed     Abstract available

  72. CUI D, Mathews P, Li G, VanCourt S, et al
    Outcomes of Sjogren's versus non-Sjogren's related dry eye in a longitudinal, tertiary clinic-based sample.
    PLoS One. 2021;16:e0261241.
    PubMed     Abstract available

    January 2020
  73. PAN Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, et al
    Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    PLoS One. 2020;15:e0231481.
    PubMed     Abstract available

  74. KHATRI S, Hansen J, Astakhova K
    Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.
    PLoS One. 2020;15:e0232010.
    PubMed     Abstract available

  75. AVOUAC J, Cauvet A, Steelandt A, Shirai Y, et al
    Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    PLoS One. 2020;15:e0232978.
    PubMed     Abstract available

  76. MOON J, Choi SH, Yoon CH, Kim MK, et al
    Gut dysbiosis is prevailing in Sjogren's syndrome and is related to dry eye severity.
    PLoS One. 2020;15:e0229029.
    PubMed     Abstract available

  77. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available

  78. KOLARZ B, Ciesla M, Dryglewska M, Rosenthal AK, et al
    Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis.
    PLoS One. 2020;15:e0233897.
    PubMed     Abstract available

  79. SACRISTAN JA, Dilla T, Diaz-Cerezo S, Gabas-Rivera C, et al
    Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.
    PLoS One. 2020;15:e0234705.
    PubMed     Abstract available

  80. ALAM J, Lee A, Lee J, Kwon DI, et al
    Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome.
    PLoS One. 2020;15:e0230667.
    PubMed     Abstract available

  81. CASANOVA-VALLVE N, Constantin-Teodosiu D, Filer A, Hardy RS, et al
    Skeletal muscle dysregulation in rheumatoid arthritis: Metabolic and molecular markers in a rodent model and patients.
    PLoS One. 2020;15:e0235702.
    PubMed     Abstract available

    Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235637.
    PubMed     Abstract available

  83. JIRSOVA K, Seidler Stangova P, Palos M, Mahelkova G, et al
    Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjogren's syndrome.
    PLoS One. 2020;15:e0231473.
    PubMed     Abstract available

  84. ORTIZ-HARO AB, Lerma-Talamantes A, Cabrera-Vanegas A, Contreras-Yanez I, et al
    Development and validation of a questionnaire assessing household work limitations (HOWL-Q) in women with rheumatoid arthritis.
    PLoS One. 2020;15:e0236167.
    PubMed     Abstract available

  85. XINQIANG S, Erqin D, Yu Z, Hongtao D, et al
    Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis.
    PLoS One. 2020;15:e0233814.
    PubMed     Abstract available

  86. DERAMBURE C, Dzangue-Tchoupou G, D'Agostino MA, Lequerre T, et al
    Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.
    PLoS One. 2020;15:e0237143.
    PubMed     Abstract available

  87. VAN BOHEEMEN L, van Beers-Tas MH, Kroese JM, van de Stadt LA, et al
    Cardiovascular risk in persons at risk of developing rheumatoid arthritis.
    PLoS One. 2020;15:e0237072.
    PubMed     Abstract available

  88. ESBENSEN BA, Stallknecht SE, Madsen ME, Hagelund L, et al
    Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis.
    PLoS One. 2020;15:e0237117.
    PubMed     Abstract available

  89. CONTRERAS-YANEZ I, Cabrera-Vanegas A, Robledo-Torres A, Caceres-Giles C, et al
    Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0237504.
    PubMed     Abstract available

  90. BURISCH J, Eigner W, Schreiber S, Aletaha D, et al
    Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233781.
    PubMed     Abstract available

  91. PINEL L, Perez-Nieto MA, Redondo M, Rodriguez-Rodriguez L, et al
    Emotional affection on a sustained attention task: The importance the aging process and depression.
    PLoS One. 2020;15:e0234405.
    PubMed     Abstract available

  92. FOSTER E, Malloy MJ, Jokubaitis VG, Wrede CDH, et al
    Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
    PLoS One. 2020;15:e0234813.
    PubMed     Abstract available

  93. JUN JH, Lee YH, Son MJ, Kim H, et al
    Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
    PLoS One. 2020;15:e0235408.
    PubMed     Abstract available

  94. DI BENEDETTO P, Cipriani P, Iacono D, Pantano I, et al
    Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    PLoS One. 2020;15:e0235326.
    PubMed     Abstract available

  95. ASLAM MM, Jalil F, John P, Fan KH, et al
    A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases.
    PLoS One. 2020;15:e0239426.
    PubMed     Abstract available

  96. ARNTZ OJ, Pieters BCH, van Lent PLEM, Koenders MI, et al
    An optimized method for plasma extracellular vesicles isolation to exclude the copresence of biological drugs and plasma proteins which impairs their biological characterization.
    PLoS One. 2020;15:e0236508.
    PubMed     Abstract available

  97. JHUN J, Moon J, Ryu J, Shin Y, et al
    Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting.
    PLoS One. 2020;15:e0241080.
    PubMed     Abstract available

  98. CHUANG CJ, Hsu CW, Lu MC, Koo M, et al
    Increased risk of developing dental diseases in patients with primary Sjogren's syndrome-A secondary cohort analysis of population-based claims data.
    PLoS One. 2020;15:e0239442.
    PubMed     Abstract available

  99. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available

  100. MORI S, Koga Y, Nakamura K, Hirooka S, et al
    Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.
    PLoS One. 2020;15:e0243110.
    PubMed     Abstract available

  101. TEITSMA XM, Devenport J, Jacobs JWG, Petho-Schramm A, et al
    Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.
    PLoS One. 2020;15:e0241189.
    PubMed     Abstract available

    Correction: Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243960.
    PubMed     Abstract available

  103. MORI A, Saito T, Takahashi M, Shibata M, et al
    Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0243729.
    PubMed     Abstract available

  104. DROZ N, Hanaway P, Hyman M, Jin Y, et al
    The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective study.
    PLoS One. 2020;15:e0240416.
    PubMed     Abstract available

  105. SHOJI J, Inada N, Tomioka A, Yamagami S, et al
    Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjogren's syndrome-associated dry eyes.
    PLoS One. 2020;15:e0242617.
    PubMed     Abstract available

  106. GATT A, Mercieca C, Borg A, Grech A, et al
    Thermal characteristics of rheumatoid feet in remission: Baseline data.
    PLoS One. 2020;15:e0243078.
    PubMed     Abstract available

  107. KOO H, Morrow CD
    Perturbation of the human gastrointestinal tract microbial ecosystem by oral drugs to treat chronic disease results in a spectrum of individual specific patterns of extinction and persistence of dominant microbial strains.
    PLoS One. 2020;15:e0242021.
    PubMed     Abstract available

  108. BUSCHHART AL, Bolten L, Volzke J, Ekat K, et al
    Periodontal pathogens alter the synovial proteome. Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice.
    PLoS One. 2020;15:e0242868.
    PubMed     Abstract available

  109. BEN-ELI H, Solomon A, Aframian DJ, Ben-Chetrit E, et al
    Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    PLoS One. 2020;15:e0244712.
    PubMed     Abstract available

    January 2019
  110. MILIC V, Colic J, Cirkovic A, Stanojlovic S, et al
    Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    PLoS One. 2019;14:e0226498.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.